New Vernon Capital Holdings Ii LLC Collegium Pharmaceutical, Inc Transaction History
New Vernon Capital Holdings Ii LLC
- $186 Million
- Q3 2024
A detailed history of New Vernon Capital Holdings Ii LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, New Vernon Capital Holdings Ii LLC holds 3,400 shares of COLL stock, worth $104,414. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,400
Previous 3,400
-0.0%
Holding current value
$104,414
Previous $109,000
20.18%
% of portfolio
0.07%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding COLL
# of Institutions
249Shares Held
37.6MCall Options Held
100KPut Options Held
10K-
Black Rock Inc. New York, NY5.79MShares$178 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$80.9 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$72.1 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$65.8 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$50.9 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.05B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...